Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Christensen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Carcinogenesis|July 31, 1998
Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbitalA J Gonzales, J G Christensen, R J Preston, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2007
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasionE C Koon, P C Ma, R Salgia, et al.
British Journal of Cancer|February 26, 2009
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cellsS Agarwal, C Zerillo, J Kolmakova, et al.
Oncogene|January 31, 2012
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cellsC Schönherr, K Ruuth, S Kamaraj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivoJ G Christensen, R E Schreck, E Chan, et al.
Carcinogenesis|July 30, 1999
Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in miceJ G Christensen, E H Romach, L N Healy, et al.
Oncogene|February 2, 2010
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitorD Ercan, K Zejnullahu, K Yonesaka, et al.
Oncogene|November 19, 2008
Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivityZ Tang, S Jiang, R Du, et al.
Oncogene|January 24, 2012
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastomaE L Carpenter, E A Haglund, E M Mace, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Carcinogenesis|July 31, 1998
Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbitalA J Gonzales, J G Christensen, R J Preston, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2007
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasionE C Koon, P C Ma, R Salgia, et al.
British Journal of Cancer|February 26, 2009
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cellsS Agarwal, C Zerillo, J Kolmakova, et al.
Oncogene|January 31, 2012
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cellsC Schönherr, K Ruuth, S Kamaraj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivoJ G Christensen, R E Schreck, E Chan, et al.
Carcinogenesis|July 30, 1999
Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in miceJ G Christensen, E H Romach, L N Healy, et al.
Oncogene|February 2, 2010
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitorD Ercan, K Zejnullahu, K Yonesaka, et al.
Oncogene|November 19, 2008
Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivityZ Tang, S Jiang, R Du, et al.
Oncogene|January 24, 2012
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastomaE L Carpenter, E A Haglund, E M Mace, et al.
Pageof 2